Azenta (AZTA) Other Non-Current Assets (2010 - 2026)
Azenta (AZTA) recorded quarterly Other Non-Current Assets of $68.4 million in Q1 2026, up 27.81% quarter-over-quarter from $53.5 million in Q4 2025, and down 24.61% on a YoY basis from $90.7 million in Q1 2025.
Azenta (AZTA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Azenta's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $68.4 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 24.61% year-over-year to $68.4 million; the TTM figure through Mar 2026 stood at $68.4 million (down 24.61% YoY), while the FY2025 annual figure was $53.5 million, changed N/A from the prior year.
- Other Non-Current Assets was $68.4 million for Q1 2026 at Azenta, up from $53.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $542.2 million in Q3 2023 to a low of $23000.0 in Q1 2023.
- Historically, Other Non-Current Assets has averaged $89.9 million across 5 years, with a median of $65.2 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets slumped 99.96% in 2023, then surged 44052.17% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $61.9 million in 2022, then gained by 24.64% to $77.2 million in 2023, then grew by 7.84% to $83.2 million in 2024, then plunged by 35.73% to $53.5 million in 2025, then advanced by 27.81% to $68.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $68.4 million (Q1 2026), $53.5 million (Q4 2025), and $73.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | 68.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.37 Mn |
| Dec 31, 2025 | 53.50 Mn |
| Sep 30, 2025 | 73.54 Mn |
| Jun 30, 2025 | 162.50 Mn |
| Mar 31, 2025 | 90.70 Mn |
| Dec 31, 2024 | 83.24 Mn |
| Sep 30, 2024 | 99.05 Mn |
| Jun 30, 2024 | 29.43 Mn |
| Mar 31, 2024 | 10.16 Mn |
| Dec 31, 2023 | 77.19 Mn |
| Sep 30, 2023 | 542.15 Mn |
| Jun 30, 2023 | 623,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 61.93 Mn |
| Sep 30, 2022 | 57.09 Mn |
| Jun 30, 2022 | 53.30 Mn |
| Mar 31, 2022 | 65.24 Mn |
| Dec 31, 2021 | 510.70 Mn |
| Sep 30, 2021 | 58.07 Mn |
| Jun 30, 2021 | 85.17 Mn |